In addition, patients with anti-MDA5 antibodies usually show relatively mild dysfunction in daily life after RP-ILD improves, although some patients may succumb to respiratory failure caused by RP-ILD despite immunosuppressive therapies. The gene discussed is IFIH1; the disease is interstitial lung disease.